海翔药业: 半年报监事会决议公告

Core Points - The company held the 9th meeting of the 7th Supervisory Board on August 28, 2025, which was legally valid and attended by all three supervisors [1] - The Supervisory Board approved the 2025 Half-Year Report and its summary, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1] - The Supervisory Board also approved the Special Report on the Use and Storage of Raised Funds for the first half of 2025, with the same unanimous voting outcome [2]